Table 4 Descriptive statistics of clinical parameters
From: Implant decontamination with phosphoric acid during surgical peri-implantitis treatment: a RCT
| Â | Control | Test | |||
|---|---|---|---|---|---|
T0 (n = 22) | T3 (n = 20) | T0 (n = 31) | T3 (n = 30) | ||
Plaque | % of sites (SD) % of implants (n) | 4.5 (12.5) 13.6 (3) | 10.0 (18.8) 25.0 (5) | 4.0 (9.3) 16.1 (5) | 2.5 (7.6) 9.7 (3) |
BoP | % of sites (SD) % of implants (n) | 86.4 (18.5) 100 (22) | 28.8 (35.6) 50 (10) | 66.1 (29.3) 96.8 (30) | 39.2 (31.3) 76.7 (23) |
SoP | % of sites (SD) % of implants (n) | 22.7 (24.3) 54.5 (12) | 5.0 (15.4) 10.0 (2) | 30.7 (20.1) 80.6 (25) | 8.3 (20.1) 20.0 (6) |
Mean PPD | Mean (SD) | 5.3 (1.1) | 3.5 (1.5) | 5.2 (1.1) | 4.1 (1.6) |
PPD ≥5 mm | % of sites (SD) % of implants (n) | 67.1 (26.0) 100 (22) | 18.8 (30.2) 35.0 (7) | 61.3 (22.2) 100 (31) | 28.3 (33.9) 46.7 (14) |
PPD ≥6 mm | % of sites (SD) % of implants (n) | 50.0 (27.8) 100 (22) | 12.5 (26.3) 25.0 (5) | 46.8 (26.4) 90.3 (28) | 24.2 (33.1) 40.0 (12) |
PPD ≥5 mm + BoP/SoP (same site) | % of sites (SD) % of implants (n) % of patients (n) | 65.9 (26.2) 100 (22) 100 (14/14) | 12.5 (25.0) 25.0 (5) 33.3 (4/12) | 54.8 (22.7) 100 (31) 100 (14/14) | 20.0 (29.7) 36.7 (11) 46.2 (6/13) |
PPD ≥6 mm + BoP/SoP (same site) | % of sites (SD) % of implants (n) % of patients (n) | 50.0 (27.8) 100 (22) 100 (14/14) | 8.8 (20.3) 20.0 (4) 33.3 (4/12) | 41.1 (24.6) 90.3 (28) 100 (14/14) | 17.5 (28.7) 33.3 (10) 46.2 (6/13) |